NCT06621758View on ClinicalTrials.gov

Communication Regarding Preclinical Dementia Diagnostic and Diagnostic Disclosure Among Patients with MCI and SCD

Not yet recruitingOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

October 15, 2024

Primary Completion Date

February 1, 2026

Study Completion Date

August 1, 2026

Conditions
Alzheimer DiseaseMild Cognitive Impairment (MCI)Subjective Cognitive Decline (SCD)
Interventions
OTHER

questionnaire

Questionnaire regarding biomarker counseling and diagnostic disclosure

All Listed Sponsors
collaborator

Toulouse University Hospital, Department of Geriatric & Internal Medicine, France

UNKNOWN

collaborator

Universitair Ziekenhuis Brussel, Department of Neurology, Belgium

UNKNOWN

collaborator

University Medical Centre Ljubljana, Department of Neurology, Slovenia

UNKNOWN

lead

Danish Dementia Research Centre

NETWORK